Get Started

ELDN

NASD Eledon Pharmaceuticals, Inc.
Oct 30, 2026 · 2:38 AM ET EOD Market Closed

$3.04 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.04, $0.18 below the day’s high of $3.22

YTD change
+101.32%
vs 20-day SMA
+28.60%
vs 200-day SMA
-1.85%

Price ranges

Previous day
$2.37 $2.81
open $2.40 close $2.76
+$0.36 (+15.00%)
Today
$2.73 $3.22
open $2.77 now $3.04
+$0.27 (+9.75%)
Past week
$2.20 $2.81
from $2.26 now $3.04
+$0.78 (+34.51%)
Past month
$2.11 $2.81
from $2.53 now $3.04
+$0.51 (+20.16%)
This year
$1.51 $4.49
from $1.51 now $3.04
+$1.53 (+101.32%)

Price & Performance

-0.30 (-8.98%) / 6M

$1.96$2.77$3.57$4.38Apr 29Jul 30Oct 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 86.7% away from all-time highs of $22.91
  • ELDN is up 101% since the beginning of the year
  • ELDN is down 28% over the past 12 months
  • ELDN is up 20% over the past 1 month
  • 8% of all ELDN investors are betting against ELDN

ELDN reads very good: price sits above one of the two key moving averages, the 12-month move is -28.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.27
Earnings momentum -42.1% Quarterly EPS growth
Quarterly change -42.1%

Valuation

P/E ratio N/A
Enterprise value $264.4M
Beta 0.01

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$88.8M
Debt$467.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $280.8M

Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in development of therapies to protect transplanted organs and prevent rejection. The firm also focuses on development of therapy to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L), a biological target with broad therapeutic potential. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $460.73 +1.97%
MRNA Moderna, Inc. $222.76 +4.01%
RVMD Revolution Medicines, Inc. $190.27 +0.82%
ROIV Roivant Sciences Ltd. $37.52 +1.10%
BNTX BioNTech SE Sponsored ADR $89.13 +1.30%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.